Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Zeo ScientifiX (ZEOX) Gains from Sales and Divestitures (2020 - 2023)

Zeo ScientifiX (ZEOX) has 4 years of Gains from Sales and Divestitures data on record, last reported at $169983.0 in Q4 2023.

  • For Q4 2023, Gains from Sales and Divestitures rose 243.36% year-over-year to $169983.0; the TTM value through Oct 2023 reached $169983.0, up 243.36%, while the annual FY2023 figure was $169983.0, 243.36% up from the prior year.
  • Gains from Sales and Divestitures reached $169983.0 in Q4 2023 per ZEOX's latest filing, down from $34.0 million in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $34.0 million in Q2 2023 and bottomed at $49506.0 in Q4 2022.
  • Average Gains from Sales and Divestitures over 4 years is $4.7 million, with a median of $583332.0 recorded in 2020.
  • Peak YoY movement for Gains from Sales and Divestitures: plummeted 92.57% in 2022, then soared 8297.93% in 2023.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $666666.0 in 2020, then changed by 0.0% to $666666.0 in 2021, then tumbled by 92.57% to $49506.0 in 2022, then soared by 243.36% to $169983.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Gains from Sales and Divestitures were $169983.0 in Q4 2023, $34.0 million in Q2 2023, and $14.0 million in Q1 2023.